University of Pennsylvania Clinical Trial Site Application for Kidney Cancer Research Consortium Award
Abstract
The purpose of the University of Pennsylvania Abramson Cancer Center Kidney Cancer Research Consortium (PENN/ACC KCRC) award is to support the development of a data sharing infrastructure using the Prometheus platform so that Penn can collaborate with other members of the KCRC in a seamless method and participate in consortium phase I and II clinical trials. Over this year one of funding, we have helped to form a governance structure for all of the members, which includes an external advisory board. We have formalized a contracting and review process between Penn and the lead coordinating site, MD Anderson Cancer Center. Following the completion of these tasks, we have both presented three clinical trials for consideration of KCRC participation and we have submitted the first KCRC translational protocol to the Penn and Central Institutional Review Boards for imminent activation at Penn. We anticipate a robust accrual to this protocol and future participation and accrual to future KCRC treatment protocols. Finally, the KCRC website has been activated.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2022
- Accession Number
- AD1192594
Entities
People
- Naomi B. Haas
Organizations
- University of Pennsylvania